Pay in 4 interest-free payments of $6.14 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
The researchers found that GLP-1 medications can reduce food noise better than behavioral therapy alone
The study had few people dropout because of side effects
Semaglutide belongs to a class of drugs known as GLP-1 receptor agonists as they resemble a hormone called glucagon-like peptide 1, which stimulates insulin production, helps to lower blood sugar levels and, due to those metabolic effects, often results in weight loss
This early suppression occurs because Semaglutide immediately begins mimicking the GLP-1 hormone, which signals the brains hypothalamus to reduce hunger and increases the time food stays in the stomach
Chronic inflammation, excess weight, and insulin resistance can cause arteries to lose flexibility, leading to increased vascular strain
Consequently, these studies help researchers observe significant changes in fat oxidation and insulin sensitivity within controlled laboratory models
